inclusion criteria: * men and women aged 18 and over * clinical status according to the who scale - 6, 7, 8 and 9 points. * verified respiratory infection covid-19 by real-time pcr (quantitative) * patient consent to use reliable contraceptive methods throughout the study and for 3 weeks after: * women who have a negative pregnancy test and use the following contraceptives: intrauterine devices, oral contraceptives, contraceptive patch, prolonged injectable contraceptives, double barrier method of contraception. women who are not fertile can also take part in the study (documented conditions: hysterectomy, tubal ligation, infertility, menopause for more than 1 year); * men using barrier contraception. the study may also involve men who are not fertile (documented conditions: vasectomy, infertility) * availability of signed and dated informed consent of the patient to participate in the study.

inclusion criteria: * men and women aged 18 and over * clinical status according to the who scale - 6, 7, 8 and 9 points. * verified respiratory infection covid-19 by real-time pcr (quantitative) * patient consent to use reliable contraceptive methods throughout the study and for 3 weeks after: * women who have a negative pregnancy test and use the following contraceptives: intrauterine devices, oral contraceptives, contraceptive patch, prolonged injectable contraceptives, double barrier method of contraception. women who are not fertile can also take part in the study (documented conditions: hysterectomy, tubal ligation, infertility, menopause for more than 1 year); * men using barrier contraception. the study may also involve men who are not fertile (documented conditions: vasectomy, infertility) * availability of signed and dated informed consent of the patient to participate in the study.

inclusion criteria: men and women aged 18 and over clinical status according to the who scale - 6, 7, 8 and 9 points. verified respiratory infection covid-19 by real-time pcr (quantitative) patient consent to use reliable contraceptive methods throughout the study and for 3 weeks after: women who have a negative pregnancy test and use the following contraceptives: intrauterine devices, oral contraceptives, contraceptive patch, prolonged injectable contraceptives, double barrier method of contraception. women who are not fertile can also take part in the study (documented conditions: hysterectomy, tubal ligation, infertility, menopause for more than 1 year); men using barrier contraception. the study may also involve men who are not fertile (documented conditions: vasectomy, infertility) availability of signed and dated informed consent of the patient to participate in the study.

inclusion criteria: men and women aged 18 and over clinical status according to the who scale - 6, 7, 8 and 9 points. verified respiratory infection covid-19 by real-time pcr (quantitative) patient consent to use reliable contraceptive methods throughout the study and for 3 weeks after: women who have a negative pregnancy test and use the following contraceptives: intrauterine devices, oral contraceptives, contraceptive patch, prolonged injectable contraceptives, double barrier method of contraception. women who are not fertile can also take part in the study (documented conditions: hysterectomy, tubal ligation, infertility, menopause for more than 1 year); men using barrier contraception. the study may also involve men who are not fertile (documented conditions: vasectomy, infertility) availability of signed and dated informed consent of the patient to participate in the study.